Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Cash from Investing Activities (2016 - 2018)

Historic Cash from Investing Activities for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to -$535000.0.

  • Armata Pharmaceuticals' Cash from Investing Activities fell 287222.22% to -$535000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was -$597000.0, marking a year-over-year decrease of 92931.03%. This contributed to the annual value of -$1.9 million for FY2024, which is 7689.94% up from last year.
  • According to the latest figures from Q4 2018, Armata Pharmaceuticals' Cash from Investing Activities is -$535000.0, which was down 287222.22% from -$11000.0 recorded in Q3 2018.
  • Armata Pharmaceuticals' 5-year Cash from Investing Activities high stood at -$2000.0 for Q2 2017, and its period low was -$831000.0 during Q2 2014.
  • In the last 5 years, Armata Pharmaceuticals' Cash from Investing Activities had a median value of -$34000.0 in 2015 and averaged -$127500.0.
  • As far as peak fluctuations go, Armata Pharmaceuticals' Cash from Investing Activities soared by 9891.7% in 2015, and later plummeted by 287222.22% in 2018.
  • Quarter analysis of 5 years shows Armata Pharmaceuticals' Cash from Investing Activities stood at -$5000.0 in 2014, then tumbled by 900.0% to -$50000.0 in 2015, then soared by 74.0% to -$13000.0 in 2016, then crashed by 38.46% to -$18000.0 in 2017, then tumbled by 2872.22% to -$535000.0 in 2018.
  • Its last three reported values are -$535000.0 in Q4 2018, -$11000.0 for Q3 2018, and -$18000.0 during Q4 2017.